Literature DB >> 7196765

[Studies on the pharmacokinetics of amoxicillin after intravenous, intramuscular and oral administration (author's transl)].

A Dalhoff, P Koeppe, D von Kobyletzki.   

Abstract

The pharmacokinetics of alpha-amino-p-hydroxybenzylpenicillin (amoxicillin) after intravenous, intramuscular and oral application were studied and the corresponding constants are reported. Following i.v. injection of 250, 500 and 1000 mg and infusion of 2 and 5 g the data are examined by means of a two- and three-compartment model, respectively. Calculations by adopting the two-compartment model reveal no significant dose dependency of the distribution constants and the serum concentration curves decline bioexponentially. A better fit of the regression curve to the experimentally determined serum concentrations is obtained by using the three-compartment model, indicating a slow and late disposition phase whose constants are significantly dose dependent. The share of this third phase in the total distribution of amoxicillin is 33% to 43%. After an i.m. injection of 250, 500 and 1000 mg amoxicillin is absorbed without any delay to 79% to 88%; the mean absorption constant is approximately 2 h-1. No significant dose dependency could be determined. Analogous results were obtained following oral administration of 250 and 500 mg. Absorption is delayed to 16 to 18 min; the mean absorption constant is 1.4 h-1 and 72% to 86% of the administered drug is absorbed without being significantly dose dependent. On the basis of the examined parameters the bioavailability of amoxicillin following extravascular administration can be regarded as reliable and safe.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196765

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

Review 1.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.

Authors:  D Adam; I de Visser; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.

Authors:  G Witkowski; H Lode; G Höffken; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

4.  Ticarcillin serum and tissue concentrations in gynecology and obstetrics.

Authors:  D von Kobyletzki; A Dalhoff; H Lindemeyer; C A Primavesi
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

5.  Nonlinearity of amoxicillin absorption kinetics in human.

Authors:  G Paintaud; G Alván; M L Dahl; A Grahnén; J Sjövall; J O Svensson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Renal excretion of intravenously infused amoxycillin and ampicillin.

Authors:  J Sjövall; D Westerlund; G Alván
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

7.  Modeling of the saturable time-constrained amoxicillin absorption in humans.

Authors:  V K Piotrovskij; G Paintaud; G Alván; T Trnovec
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.